A5009645211- Breast Cancer Treatment Studies
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Surgical Treatments
- Metabolism, Diabetes, and Cancer
- Herpesvirus Infections and Treatments
- Cancer Risks and Factors
- Toxin Mechanisms and Immunotoxins
- Estrogen and related hormone effects
- Colorectal and Anal Carcinomas
- Advanced Breast Cancer Therapies
- Cytomegalovirus and herpesvirus research
University of Pavia
2025
Institut Jules Bordet
2025
Policlinico San Matteo Fondazione
2022-2023
Istituti di Ricovero e Cura a Carattere Scientifico
2022-2023
Herpes zoster (HZ) is caused by the reactivation of latent varicella virus (VZV). Severe immunocompromising conditions, such as solid tumors, have been largely associated with an increased risk for HZ due to waning VZV-specific cellular immunity. With approval adjuvanted glycoprotein E (gE)-based recombinant vaccine (RZV; Shingrix™, GSK) also in immunocompromised subjects, considered a vaccine-preventable disease changing perspectives subjects. To date, no clinical trial has evaluated...
Abstract Background Conventional Right Colectomy with D2 lymphadenectomy (RC-D2) currently represent the most common surgical treatment of right-sided colon cancer (RCC). However, whether it should be still considered a standard care, or replaced by routine more extended D3 remains unclear. In present study, we aim to critically review patterns relapse and survival outcomes obtained from our 11-year experience RC-D2. Methods Clinical data 489 patients who underwent RC-D2 for RCC at two...